carvedilol has been researched along with angiotensinogen in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Afzal, S; Andersen, JT; Broedbaek, K; Børglum, AD; Jimenez-Solem, E; Køber, L; Nyegaard, M; Petersen, M; Poulsen, HE; Stender, S; Torp-Pedersen, C | 1 |
1 other study(ies) available for carvedilol and angiotensinogen
Article | Year |
---|---|
Effect of specific ADRB1/ADRB2/AGT genotype combinations on the association between survival and carvedilol treatment in chronic heart failure: a substudy of the ECHOS trial.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adult; Aged; Aged, 80 and over; Angiotensinogen; Carbazoles; Carvedilol; Chronic Disease; Female; Genotype; Heart Failure; Humans; Male; Middle Aged; Phenotype; Propanolamines; Proportional Hazards Models; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Retrospective Studies; Survival Analysis | 2012 |